38 related articles for article (PubMed ID: 20038232)
1. The optimal dose of arsenic trioxide induced opposite efficacy in autophagy between K562 cells and their initiating cells to eradicate human myelogenous leukemia.
Guo Z; Meng M; Geng S; Du Z; Zheng Y; Yao J; Li Z; Han G; Lin H; Du G
J Ethnopharmacol; 2017 Jan; 196():29-38. PubMed ID: 27965050
[TBL] [Abstract][Full Text] [Related]
2. Phase 1/2 study of the combination of 5-aza-2'-deoxycytidine with valproic acid in patients with leukemia.
Garcia-Manero G; Kantarjian HM; Sanchez-Gonzalez B; Yang H; Rosner G; Verstovsek S; Rytting M; Wierda WG; Ravandi F; Koller C; Xiao L; Faderl S; Estrov Z; Cortes J; O'brien S; Estey E; Bueso-Ramos C; Fiorentino J; Jabbour E; Issa JP
Blood; 2006 Nov; 108(10):3271-9. PubMed ID: 16882711
[TBL] [Abstract][Full Text] [Related]
3. Azacitidine-Hesperetin Combination Induces S-phase Cell Cycle Arrest and Apoptosis in Human Leukemia Cells.
Lai KM; Tseng RH; Shih YH; Huang YC
Anticancer Res; 2024 Mar; 44(3):1033-1044. PubMed ID: 38423637
[TBL] [Abstract][Full Text] [Related]
4. Retinoic acid and arsenic trioxide induce lasting differentiation and demethylation of target genes in APL cells.
Huynh TT; Sultan M; Vidovic D; Dean CA; Cruickshank BM; Lee K; Loung CY; Holloway RW; Hoskin DW; Waisman DM; Weaver ICG; Marcato P
Sci Rep; 2019 Jul; 9(1):9414. PubMed ID: 31263158
[TBL] [Abstract][Full Text] [Related]
5. Effects of chidamide and its combination with decitabine on proliferation and apoptosis of leukemia cell lines.
Mao J; Li S; Zhao H; Zhu Y; Hong M; Zhu H; Qian S; Li J
Am J Transl Res; 2018; 10(8):2567-2578. PubMed ID: 30210693
[TBL] [Abstract][Full Text] [Related]
6. The Synergistic Effects of Decitabine Combined with Arsenic Trioxide (ATO) in the Human Myelodysplastic Syndrome Cell Line SKM-1.
Wu P; Liu L; Weng J; Geng S; Deng C; Lu Z; Luo C; Du X
Indian J Hematol Blood Transfus; 2016 Dec; 32(4):412-417. PubMed ID: 27812249
[TBL] [Abstract][Full Text] [Related]
7. Palliative chemotherapy followed by methylation inhibitor in high-risk acute myeloid leukemia: An
Ding B; Wang Z; Jiang X; Li X; Wang C; Zhong Q; Jiang L; Dai M; Zhang YU; Wei QI; Meng F
Mol Clin Oncol; 2015 Sep; 3(5):1139-1144. PubMed ID: 26623066
[TBL] [Abstract][Full Text] [Related]
8. Azacytidine sensitizes acute myeloid leukemia cells to arsenic trioxide by up-regulating the arsenic transporter aquaglyceroporin 9.
Chau D; Ng K; Chan TS; Cheng YY; Fong B; Tam S; Kwong YL; Tse E
J Hematol Oncol; 2015 May; 8():46. PubMed ID: 25953102
[TBL] [Abstract][Full Text] [Related]
9. Fruits and barks extracts of Zanthozyllum heitzii a spice from Cameroon induce mitochondrial dependent apoptosis and Go/G1 phase arrest in human leukemia HL-60 cells.
Pieme CA; Santosh GK; Tekwu EM; Askun T; Aydeniz H; Ngogang JY; Bhushan S; Saxena AK
Biol Res; 2014 Oct; 47(1):54. PubMed ID: 25723957
[TBL] [Abstract][Full Text] [Related]
10. Combining the differentiating effect of panobinostat with the apoptotic effect of arsenic trioxide leads to significant survival benefit in a model of t(8;21) acute myeloid leukemia.
Salmon JM; Bots M; Vidacs E; Stanley KL; Atadja P; Zuber J; Johnstone RW
Clin Epigenetics; 2015; 7(1):2. PubMed ID: 25628765
[TBL] [Abstract][Full Text] [Related]
11. Sequential combination of decitabine and idarubicin synergistically enhances anti-leukemia effect followed by demethylating Wnt pathway inhibitor promoters and downregulating Wnt pathway nuclear target.
Li K; Hu C; Mei C; Ren Z; Vera JC; Zhuang Z; Jin J; Tong H
J Transl Med; 2014 Jun; 12():167. PubMed ID: 24923330
[TBL] [Abstract][Full Text] [Related]
12. Matrine inhibits proliferation and induces apoptosis via BID-mediated mitochondrial pathway in esophageal cancer cells.
Wang Q; Du H; Geng G; Zhou H; Xu M; Cao H; Zhang B; Song G; Hu T
Mol Biol Rep; 2014 May; 41(5):3009-20. PubMed ID: 24510386
[TBL] [Abstract][Full Text] [Related]
13. Synergistic Apoptosis-Inducing Antileukemic Effects of Arsenic Trioxide and Mucuna macrocarpa Stem Extract in Human Leukemic Cells via a Reactive Oxygen Species-Dependent Mechanism.
Lu KH; Lee HJ; Huang ML; Lai SC; Ho YL; Chang YS; Chi CW
Evid Based Complement Alternat Med; 2012; 2012():921430. PubMed ID: 21826188
[TBL] [Abstract][Full Text] [Related]
14. Growth-inhibiting effects of arsenic trioxide plus epigenetic therapeutic agents on leukemia cell lines.
Peng CY; Jiang J; Zheng HT; Liu XS
Leuk Lymphoma; 2010 Feb; 51(2):297-303. PubMed ID: 20038232
[TBL] [Abstract][Full Text] [Related]
15. Synergism of arsenic trioxide and MG132 in Raji cells attained by targeting BNIP3, autophagy, and mitochondria with low doses of valproic acid and vincristine.
Cavaliere V; Lombardo T; Costantino SN; Kornblihtt L; Alvarez EM; Blanco GA
Eur J Cancer; 2014 Dec; 50(18):3243-61. PubMed ID: 25446377
[TBL] [Abstract][Full Text] [Related]
16. The mechanism of synergistic effects of arsenic trioxide and rapamycin in acute myeloid leukemia cell lines lacking typical t(15;17) translocation.
Dembitz V; Lalic H; Ostojic A; Vrhovac R; Banfic H; Visnjic D
Int J Hematol; 2015 Jul; 102(1):12-24. PubMed ID: 25758096
[TBL] [Abstract][Full Text] [Related]
17. Preclinical evaluation of antineoplastic activity of inhibitors of DNA methylation (5-aza-2'-deoxycytidine) and histone deacetylation (trichostatin A, depsipeptide) in combination against myeloid leukemic cells.
Shaker S; Bernstein M; Momparler LF; Momparler RL
Leuk Res; 2003 May; 27(5):437-44. PubMed ID: 12620295
[TBL] [Abstract][Full Text] [Related]
18. Molecular targets of arsenic trioxide in malignant cells.
Miller WH
Oncologist; 2002; 7 Suppl 1():14-9. PubMed ID: 11961205
[TBL] [Abstract][Full Text] [Related]
19. Arsenic-induced apoptosis in malignant cells in vitro.
Akao Y; Yamada H; Nakagawa Y
Leuk Lymphoma; 2000 Mar; 37(1-2):53-63. PubMed ID: 10721769
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
